TORONTO, ON and NEW YORK, NY / ACCESSWIRE / June 2, 2021 / Binovi Technologies Corp., (Binovi) (TSXV:VISN)(OTCQB:BNVIF) today provided an update with respect to the Company's efforts in bringing optometrist-led
Highlights: COVID-19 home confinement of children is associated with up to 3X increase in prevalence of myopia in children 6 to 8 years old18 months into the global COVID-19 Pandemic, VTI sees continued expansion of users, and provides benefits to eye care professionalsNaturalVue® Multifocal lenses show great promise in helping curtail the current myopia epidemicUsage
Gene therapy using engineered virus partially restores blind patient s vision Follow Us
Question of the Day
Now that we know the military is investigating Unidentified Aerial Phenomena (UFOs), what do you think they might be?
Question of the Day By Shen Wu Tan - The Washington Times - Tuesday, May 25, 2021
Doctors for the first time have partially restored the vision of a blind patient using gene therapy to inject a genetically engineered virus into his eye.
Researchers performed the therapy on a 58-year-old man who was diagnosed 40 years ago with an inherited eye disease called retinitis pigmentosa, which is loss of vision due to a breakdown and loss of cells in the retina.
Gene therapy using engineered virus partially restores blind patient s vision Follow Us
Question of the Day
By Shen Wu Tan - The Washington Times - Tuesday, May 25, 2021
Doctors for the first time have partially restored the vision of a blind patient using gene therapy to inject a genetically engineered virus into his eye.
Researchers performed the therapy on a 58-year-old man who was diagnosed 40 years ago with an inherited eye disease called retinitis pigmentosa, which is loss of vision due to a breakdown and loss of cells in the retina.
The optogenetics therapy, which involves controlling nerve cells via light, allowed the patient to pinpoint objects including a notebook, small staple box and tumbler he couldn’t see before when wearing light-stimulating goggles, according to the study published Monday in Nature Medicine.